PR Newswire News
- 00:22:00
- Ascentage Pharma Announces 2022 Annual Results Including Strong Sales of Olverembatinib and Steady Progress in Transition Towards Biopharma
2023-03-23
- 22:38:00
- Jacobio Pharma Announces 2022 Annual Results
- 20:50:00
- CARsgen Announced 2022 Annual Results and Business Updates
- 20:37:00
- Genes Tech Group Announces 2022 Annual Results
- 20:09:00
- WuXi Biologics Reports Remarkable 2022 Annual Results
- 19:25:00
- ESR achieves outstanding financial and operational results with record highs for FY2022[1]
- 17:35:00
- Zhihu Inc. Reports Unaudited Fourth Quarter and Fiscal Year 2022 Financial Results
- 17:09:00
- Dignitana enters Hong Kong market with leading distributor Science International Corporation
- 17:00:00
- Yum China to Report First Quarter 2023 Financial Results
- 15:56:00
- UnionPay Joins Forces with Kai Shing to Provide Property Management Fee QR Code Payment Services for Over 100,000 Property Units in Hong Kong
- 15:26:00
- Zylox-Tonbridge Assisted Turkish Hospitals in Post-earthquake Recovery
- 12:36:00
- Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA® (pembrolizumab) for patients with cancer
- 11:15:00
- 3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2%
2023-03-22
- 23:32:00
- Sisram Medical Announces 2022 Annual Results
- 22:02:00
- Goldpac Announces 2022 Annual Results
- 22:00:00
- BingX Launches a $10M Fund to Boost Social Trading Ecosystem
- 19:08:00
- Fusion Bank Launches Business Banking, Empowering SMEs to Capture Global Opportunities
- 17:00:00
- Tencent Music Entertainment Group Announces Fourth Quarter and Full-Year 2022 Unaudited Financial Results
- 15:51:00
- PR Newswire Solidifies Position in APAC Region with Enhanced Content and Journalist Ecosystem
- 15:22:00
- Kintor Pharma's KX-826 and GT20029 for Treatment of Androgenetic Alopecia (AGA) and Acne Presented at AAD 2023
2023-03-21
